← All Cases Coverage by Bryan K. Randolph · BrynoDC

FDA v. Alliance for Hippocratic Medicine

No. 23-10362 SCOTUS · Decided Teaching/Historical SCOTUS
Argued: May 17, 2023 Decided: Sep 16, 2024
Court
5th Cir.
ca5
Argued
May 17, 2023
Decided
Sep 16, 2024
Filed
Apr 10, 2023
Filed (CL)
Apr 10, 2023
CL Status
terminated

BrynoDC Coverage 2 videos

TikTok
Jan 14, 2026
TikTok

The Conclusion

**Alliance for Hippocratic Medicine demonstrates standing doctrine's clarity: the Supreme Court unanimously held that plaintiffs must demonstrate concrete injury, not policy disagreement.** Anti-abortion physicians challenging the FDA's mifepristone approval failed to show they were personally harmed. The 9-0 decision illustrated how settled this constitutional gate-keeping principle remains.

Court -
FiledApr 10, 2023
CL Statusterminated
View on CourtListener →

No circuit court data for this case.

Cert Granted -
Statusterminated
Filed (CL)Apr 10, 2023
View on CourtListener →
SCOTUS TMR-6a3573bf May 28, 2026

Cited By (16)

  • United States v. Texas SCOTUS

    The United States v. Texas case concerns the scope of judicial remedies available under the Administrative Procedure …

  • Food & Drug Administration v. Alliance for Hippocratic Medicine SCOTUS

    The case concerns whether doctors and medical organizations have legal standing to challenge the FDA's regulations pe…

  • Murthy v. Missouri SCOTUS

    Murthy v. Missouri is a case challenging the federal government's alleged pressure on social media platforms to suppr…

  • Diamond Alternative Energy LLC v. EPA SCOTUS

    Diamond Alternative Energy LLC v. EPA involves a legal challenge to EPA regulations affecting fuel producers' sales a…

  • Bost v. Illinois State Board of Elections SCOTUS

    A candidate challenges the Illinois State Board of Elections' regulation or enforcement of election rules affecting t…

  • United States v. Texas SCOTUS

    The United States v. Texas case concerns the scope of judicial remedies available under the Administrative Procedure …

  • Food & Drug Administration v. Alliance for Hippocratic Medicine SCOTUS

    The case concerns whether doctors and medical organizations have legal standing to challenge the FDA's regulations pe…

  • Murthy v. Missouri SCOTUS

    Murthy v. Missouri is a case challenging the federal government's alleged pressure on social media platforms to suppr…

  • Diamond Alternative Energy LLC v. EPA SCOTUS

    Diamond Alternative Energy LLC v. EPA involves a legal challenge to EPA regulations affecting fuel producers' sales a…

  • Bost v. Illinois State Board of Elections SCOTUS

    A candidate challenges the Illinois State Board of Elections' regulation or enforcement of election rules affecting t…

  • Food & Drug Administration v. Alliance for Hippocratic Medicine SCOTUS

    Food & Drug Administration v. Alliance for Hippocratic Medicine (23-235)

  • Moody v. NetChoice SCOTUS

    Moody v. NetChoice (22-277)

  • Murthy v. Missouri SCOTUS

    Murthy v. Missouri (23-411)

  • Corner Post v. Federal Reserve Board SCOTUS

    Corner Post v. Federal Reserve Board (22-1008)

  • Diamond Alternative Energy LLC v. EPA SCOTUS

    Diamond Alternative Energy LLC v. EPA (24-7)

  • Bost v. Illinois State Board of Elections SCOTUS

    Bost v. Illinois State Board of Elections (24-568)


Case Analysis

Overview

In 2024, the Supreme Court ruled 9-0 that a group of anti-abortion doctors lacked standing to challenge the FDA's approval of mifepristone. The medication used in the majority of U.S. Abortions. Because they couldn't show any personal injury from its approval or use. The unanimous decision made it as much a case about access to courts as about abortion: disagreeing with a policy isn't enough to sue over it; you have to show the policy actually harmed you specifically. Bryan covers it as a standing case, and a reminder that 9-0 opinions are rare enough to mean something. When every justice agrees, the legal question is clean.

Conclusion

**Alliance for Hippocratic Medicine demonstrates standing doctrine's clarity: the Supreme Court unanimously held that plaintiffs must demonstrate concrete injury, not policy disagreement.** Anti-abortion physicians challenging the FDA's mifepristone approval failed to show they were personally harmed. The 9-0 decision illustrated how settled this constitutional gate-keeping principle remains.

Notes

602 U.S. 367 (2024)

Subscribe on Substack ↗

This tracker is maintained by BrynoDC and is free because readers fund it. Support